Table 3B. Relationships between GNRI and clinicopathological features in patients with ESCC stage II.
| Characteristics | Total patients | GNRI | ||
|---|---|---|---|---|
| < 97.1 (n = 20) | ≥ 97.1 (n = 21) | p value | ||
| Age (years) | 72 (55–84) | 65 (50–77) | 0.0732 | |
| Sex | 0.6740 | |||
| Male | 36 | 18 | 18 | |
| Female | 5 | 2 | 3 | |
| BMI | 19.1 (13.1–24.4) | 20.7 (17.9–27.5) | 0.0123 | |
| WBC | 4460 (3070–11360) | 6120 (3920–11340) | 0.0489 | |
| Neutrophil | 2814 (1220–7168) | 3672 (2347–8222) | 0.0446 | |
| Lymphocyte | 1144 (160–3400) | 1600 (778–3330) | 0.1337 | |
| Platelet | 19.5 (9.4–39.7) | 21.7 (13.6–41.8) | 0.4416 | |
| Location of tumor | 0.6296 | |||
| Ce | 3 | 1 | 2 | |
| Ut | 6 | 3 | 3 | |
| Mt | 16 | 9 | 7 | |
| Lt | 11 | 6 | 5 | |
| Ae | 5 | 1 | 4 | |
| Tumor size (mm) | 4.0 (2.0–8.0) | 4.8 (0.5–38.0) | 0.9792 | |
| Depth of tumor | 0.2220 | |||
| T1a–1b | 17 | 6 | 11 | |
| 2 | 3 | 1 | 2 | |
| 3 | 21 | 13 | 8 | |
| 4a–4b | 0 | 0 | 0 | |
| Lymph node metastasis | 0.1426 | |||
| N0 | 21 | 13 | 8 | |
| N1 | 19 | 7 | 12 | |
| N2 | 1 | 0 | 1 | |
| N3 | 0 | 0 | 0 | |
| Operation time (min) | 614 (270–1073) | 633 (395–1258) | 0.7741 | |
| Intraoperative blood loss (ml) | 710 (0–2250) | 560 (0–2620) | 0.5228 | |
| SCC antigen | 1.1 (0.1–6.2) | 0.9 (0.1–2.1) | 0.3018 | |
| Albumin | 3.4 (2.8–4.2) | 4.2 (3.6–4.9) | < 0.0001 | |
| CRP | 0.33 (0.01–2.25) | 0.14 (0.02–1.50) | 0.0096 | |